What Cleerly Provides
Standard cardiac CT imaging produces a coronary artery calcium (CAC) score.
This metric quantifies calcified plaque, the stable, hardened deposits that
develop over time. A higher score correlates with increased cardiovascular risk.
A score of zero is often interpreted as reassuring.
The limitation is that calcified plaque is stable plaque. The dangerous variety,
soft plaque, is not calcified. It is lipid-rich, unstable, and prone to rupture.
Most heart attacks result from rupture of soft plaque rather than erosion of calcified
deposits. A patient with a zero calcium score may harbor significant soft plaque
that the standard scoring method cannot detect.
Know your vascular age
Take the free calculator. 15 questions. Your estimated vascular age score in minutes.
Take the Free Calculator →
Cleerly uses artificial intelligence to analyze coronary CT angiography (CCTA)
images in detail. The platform quantifies total plaque burden, differentiates
between plaque types (calcified, fibrous, lipid-rich), and measures stenosis
percentage with precision that visual interpretation cannot match.
Finding a Cleerly-Compatible Imaging Center
Cleerly is an analysis platform rather than an imaging provider. The process requires
obtaining a CCTA scan from a compatible imaging center, then having those
images analyzed through Cleerly's AI platform.
The Gap Between Data and Action
Cleerly produces detailed reports. A patient receives precise quantification
of plaque burden by type and location. The data is comprehensive. The question
that follows is less straightforward: what should be done about these findings?
Most cardiologists have limited experience interpreting Cleerly reports. The
platform is relatively new, and the detailed plaque characterization it provides
exceeds what traditional training emphasized. A patient may receive a report
showing significant soft plaque burden and find that their local cardiologist
recommends the same interventions they would have recommended based on conventional
risk factors alone: statins, blood pressure management, lifestyle modification.
The detailed data deserves an equally detailed response. Knowing that soft plaque
exists is valuable. Knowing how to stabilize or reverse it requires expertise
beyond standard cardiovascular care.
How GRN Labs Works with Cleerly Data
GRN Labs provides educational resources and data-driven audits that help
individuals understand their Cleerly results in greater depth. Our review
addresses questions that standard reports leave open: What factors may be
contributing to plaque formation at the endothelial level? Is the glycocalyx
intact? What biomarkers indicate whether nitric oxide production
is compromised?
The GRN protocol tracks progress through biomarkers and, when appropriate,
repeat imaging. The goal is measurable improvement over a defined timeframe rather than indefinite management of static risk.